Key Highlights
- EPS of USD 0.21 beat the consensus estimate of USD 0.18, while GAAP diluted loss per share was USD 0.13.
- Revenues from continuing operations were USD 481.6 million, down 9.2%, while recurring revenues rose 0.7% to USD 444.1 million.
- The LS&H sale closed October 6, 2026, bringing USD 488.4 million in cash plus a USD 75.0 million senior note.
- Total Debt outstanding fell to USD 4,176.1 million from USD 4,469.9 million at year end 2025.
Clarivate Plc (NYSE:CLVT) reported third quarter 2026 revenues of USD 481.6 million from continuing operations, down 9.2% from USD 530.3 million a year earlier. The figure excludes the LS&H business, now reported as discontinued operations, and compares with a consensus estimate of USD 566.77 million. Recurring revenues rose 0.7% to USD 444.1 million, while transactional revenues dropped 57.9% to USD 37.5 million. EPS of USD 0.21 compared with a consensus estimate of USD 0.18. GAAP diluted loss per share was USD 0.13, made up of a USD 0.04 loss from continuing operations and a USD 0.09 loss from discontinued operations.
Segment Revenue Fell on Product Wind-Downs While Margins Held
Academia & Government revenues fell 13.7% to USD 286.9 million, with product group wind-downs outweighing organic growth of 0.9% from new sales and pricing actions. Intellectual Property revenues slipped 1.6% to USD 194.7 million. Segment adjusted EBITDA was USD 134.6 million for Academia & Government against USD 146.3 million, and USD 86.7 million for Intellectual Property against USD 81.8 million, for a reportable segment total of USD 221.3 million against USD 228.1 million. The loss from continuing operations was USD 26.4 million versus USD 24.9 million, and total net loss was USD 80.8 million, including a USD 62.2 million Goodwill Impairment and a USD 10.1 million loss tied to classifying LS&H as held for sale.
LS&H Sale Terms and Restructuring
The company said the LS&H sale supports a shift toward the Academia & Government and Intellectual Property businesses and a stronger Balance Sheet through reduced indebtedness. At close it received USD 488.4 million in cash, net of closing costs and Working Capital adjustments, along with a USD 75.0 million unsecured senior note and deferred cash consideration of USD 25.0 million payable by January 31, 2028. Restructuring costs under the Value Creation Plan were USD 4.5 million in the quarter against USD 7.9 million a year earlier, covering severance and exit and disposal costs. Unallocated corporate costs of USD 3.1 million represent costs once allocated to LS&H that did not transfer with the sale.
Sale Proceeds, Debt and Cash Against September 30 Balances
Cash proceeds of USD 488.4 million at the October 6 close compare with total debt outstanding of USD 4,176.1 million and cash, including restricted cash, of USD 257.0 million at September 30, down from USD 329.2 million at year end 2025. Nine month Operating Cash Flow was USD 399.0 million against USD 468.6 million a year earlier. Interest expense, net was USD 61.0 million in the quarter against USD 68.5 million, and nine month restructuring costs were USD 24.9 million against USD 34.3 million. The USD 25.0 million deferred payment is due no later than January 31, 2028.


_11_20_2026_14_55_23_118425.jpg)



Please wait processing your request...